熱門資訊> 正文

Imunon申请出售最多500万股

2024-08-30 03:12

Imunon, Inc. - Common Stock(IMNN) 0
Formfactor(FORM) 0

Biotechnology company Imunon (NASDAQ:IMNN) filed a preliminary prospectus to sell up to 5M shares of common stock.
The company said the prospectus does not constitute an offer to sell.
FORM S-1

More on Imunon

Imunon, Inc. (IMNN) Q2 2024 Earnings Call Transcript
Imunon stock rallies 157% on Phase 2 study results for IMNN-001
Seeking Alpha’s Quant Rating on Imunon
Historical earnings data for Imunon
Financial information for Imunon

推薦文章

風險及免責提示：以上內容僅代表作者的個人立場和觀點，不代表華盛的任何立場，華盛亦無法證實上述內容的真實性、準確性和原創性。投資者在做出任何投資決定前，應結合自身情況，考慮投資產品的風險。必要時，請諮詢專業投資顧問的意見。華盛不提供任何投資建議，對此亦不做任何承諾和保證。